Novo Nordisk A/S-BNONOF
13F holders, Q1 2024 (March 31)3holders
$127.22avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Novo Nordisk A/S-B (NONOF) in their 13F filings. The largest holders were Kennedy Capital Management LLC ($13.6M), Atlas Capital Advisors Inc. ($660K) and GAMMA Investing LLC ($33K).
- Company
- Novo Nordisk A/S-B
- CUSIP
- K72807140
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $660K |
| Exits | 0 | $0 |
Ownership 3 holders
| Kennedy Capital Management LLC | 0.28% | Add +166.6% | 107,141 | $13.6M |
| Atlas Capital Advisors Inc. | 0.10% | New | 5,218 | $660K |
| GAMMA Investing LLC | 0.01% | No change | 258 | $33K |
"% of holder's portfolio" is NONOF's weight in each manager's 13F, not the share of Novo Nordisk A/S-B the manager owns.